Related Experiment Videos
Metastatic epidural spinal cord compression: current concepts and treatment
R Grant1, S M Papadopoulos, H M Sandler
1Department of Clinical Neurosciences-Neurology Unit, Western General Hospital, Edinburgh, Scotland, UK.
Journal of Neuro-Oncology
|January 1, 1994
Summary
Metastatic epidural spinal cord compression (MESCC) is a cancer emergency. Early diagnosis and treatment improve outcomes, but delayed care significantly reduces recovery chances for ambulatory and non-ambulatory patients.
Area of Science:
- Oncology
- Neurosurgery
- Radiology
Background:
- Metastatic epidural spinal cord compression (MESCC) affects 5-10% of cancer patients, presenting a critical medical emergency.
- Prognosis for ambulation and functional recovery is strongly linked to early diagnosis and treatment, with non-ambulatory patients facing significantly poorer outcomes.
- Recent advancements have improved understanding, management, and treatment strategies for MESCC.
Purpose of the Study:
- To review recent advances in the understanding, diagnosis, and treatment of MESCC.
- To highlight the impact of early intervention on patient prognosis.
- To discuss the role of new imaging modalities and surgical techniques.
Main Methods:
- Review of recent pathophysiological and pharmacological animal studies.
- Audit of standard and advanced imaging techniques, including magnetic resonance imaging (MRI).
- Analysis of evolving surgical philosophies and technical innovations.
Main Results:
- Recent research has provided new insights into MESCC disease mechanisms.
- Guidelines for patient evaluation have been revised based on imaging audits.
- New surgical approaches are emerging, sparking both interest and debate.
Conclusions:
- Improved clinical awareness and advanced imaging can lead to earlier diagnosis of MESCC.
- Timely and appropriate treatment is crucial for optimizing patient outcomes and preserving function.
- Continued research and technological advancements are vital for improving MESCC management.